Fatigue and Inspiratory Muscles Training Against Resistance in Patients With Multiple Sclerosis With Severe Disabilities

Stopped earlyNot a drug-phase studyProgressive MSNCT02726672

What it found

Stopped

The trial ended early for another reason (see below).

Reason given: lack of recruitment

This trial finished 8 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • respiratory rehabilitation using Powerbreathe

What it measured

Main measures

  • Fatigue graded according to EMIF-SEP questionnaire

    3 months

    Fatigue

Other measures (13)

  • Sleep disorders graded according to the Epworth Sleepiness Scale

    3 months

    Mood and sleep
  • Quality of life graded according to the SEP-59 questionnaire

    3 months

    Quality of life (reported by participants)
  • Maximal inspiratory pressure graded according to the Black and Hyatt method

    3 months

    Physical function
  • Maximal expiratory pressure graded according to Black and Hyatt method

    3 months

  • Forced vital capacity (FVC) graded with a portable spirometer

    3 months

  • Tidal volume graded with a portable spirometer

    3 months

  • Forced expiratory volume in one second (FEV1) graded with a portable spirometer

    3 months

  • FEV1/ FVC ratio graded with a portable spirometer

    3 months

  • Energy consumption during repeated effort

    3 months

  • Depression graded according to the French version of the Beck Depression Inventory Fast-Screen

    3 months

    Mood and sleep

Who could take part

Progressive MS · 18 to 65 · EDSS 6 to 7

Show the full criteria

Inclusion criteria

* Patient with remitting or progressive multiple sclerosis defined by McDonald criteria revised in 2005, with an EDSS between 6 and 7,5 * Aged between 18 and 65 years * Patients able to maintain the Powerbreathe * Not to have had a flare-up since at least 6 weeks * Patients at least 4 weeks since a corticoid bolus * Patients at least 6 weeks since a botulinum toxin injection * Patients at least 4 weeks since a pulmonary infection * Questionnaire EMIF-SEP >= 55 * Patients given their informed consent * Patients who benefit or are affiliated to a social security regimen

Exclusion criteria

* Patients with neurologic antecedents other that multiple sclerosis * Patients with respiratory disorders other than those induced by multiple sclerosis * Patients with orthopedic, cardiac, and rheumatologic invalidating antecedents * Patients with comprehension or cognitive disorders impeding the realization of rehabilitation * Pregnant women * Patients under legal guardianship, or safeguard of justice * Patients participating or planning participate within the 3 months of the study to another clinical research project

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The purpose of this study is to assess the effect of a training of the inspiratory muscles against resistance at home during 10 weeks in multiple sclerosis patients with a severe disability.

Papers

    Loading reviews and guidelines…

    History

      1. Started

        Feb 2016

      2. Main results due

        May 2018

      3. Finished

        Nov 2018

      Assembled by software from public sources.